ADVM: Adverum Biotechnologies Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Adverum Biotechnologies Inc (ADVM).
$97.15M Market Cap.
ADVM Market Cap. (MRY)
ADVM Shares Outstanding (MRY)
ADVM Assets (MRY)
Total Assets
$179.84M
Total Liabilities
$109.13M
Total Investments
$65.04M
ADVM Income (MRY)
Revenue
$1.00M
Net Income
-$130.93M
Operating Expense
$140.16M
ADVM Cash Flow (MRY)
CF Operations
-$92.46M
CF Investing
-$41.89M
CF Financing
$120.00M
ADVM Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $179,841,000 (15.45%) | $155,768,000 (-49.49%) | $308,372,000 (-29.87%) | $439,727,000 (-8.88%) |
Assets Current | $131,300,000 (27.76%) | $102,773,000 (-46.08%) | $190,595,000 (-39.90%) | $317,145,000 (-27.00%) |
Assets Non-Current | $48,541,000 (-8.40%) | $52,995,000 (-55.00%) | $117,777,000 (-3.92%) | $122,582,000 (154.69%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $70,714,000 (5.19%) | $67,222,000 (-62.97%) | $181,518,000 (-42.59%) | $316,185,000 (-27.20%) |
Property Plant & Equipment Net | $45,218,000 (-9.18%) | $49,788,000 (-56.27%) | $113,861,000 (-4.37%) | $119,060,000 (152.78%) |
Cash & Equivalents | $62,628,000 (-18.64%) | $76,976,000 (8.52%) | $70,934,000 (93.29%) | $36,698,000 (-42.14%) |
Accumulated Other Comprehensive Income | -$407,000 (13.95%) | -$473,000 (69.11%) | -$1,531,000 (-114.43%) | -$714,000 (-173.56%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $65,039,000 (202.14%) | $21,526,000 (-81.63%) | $117,158,000 (-56.77%) | $270,993,000 (-26.22%) |
Investments Current | $65,039,000 (202.14%) | $21,526,000 (-81.63%) | $117,158,000 (-56.77%) | $270,993,000 (-26.22%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $6,478,000 (0%) |
Trade & Non-Trade Payables | $1,610,000 (-16.19%) | $1,921,000 (-14.16%) | $2,238,000 (61.36%) | $1,387,000 (-50.64%) |
Accumulated Retained Earnings (Deficit) | -$1,066,951,000 (-13.99%) | -$936,024,000 (-16.62%) | -$802,612,000 (-23.85%) | -$648,076,000 (-28.96%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $86,037,000 (25.48%) | $68,565,000 (-26.72%) | $93,561,000 (-7.46%) | $101,108,000 (285.39%) |
Debt Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Debt Non-Current | $86,037,000 (25.48%) | $68,565,000 (-26.72%) | $93,561,000 (-7.46%) | $101,108,000 (285.39%) |
Total Liabilities | $109,127,000 (23.24%) | $88,546,000 (-30.20%) | $126,854,000 (2.68%) | $123,542,000 (156.20%) |
Liabilities Current | $22,898,000 (14.60%) | $19,981,000 (-38.04%) | $32,246,000 (51.25%) | $21,320,000 (2.15%) |
Liabilities Non-Current | $86,229,000 (25.76%) | $68,565,000 (-27.53%) | $94,608,000 (-7.45%) | $102,222,000 (273.77%) |
ADVM Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $1,000,000 (-72.22%) | $3,600,000 (0%) | $0 (0%) | $7,500,000 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $63,118,000 (14.64%) | $55,056,000 (-4.84%) | $57,858,000 (-10.22%) | $64,441,000 (44.35%) |
Research & Development Expense | $77,041,000 (-0.57%) | $77,486,000 (-21.95%) | $99,277,000 (11.32%) | $89,181,000 (21.65%) |
Operating Expenses | $140,159,000 (5.75%) | $132,542,000 (-15.65%) | $157,135,000 (2.29%) | $153,622,000 (30.24%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | -$1,078,000 (-1556.76%) | $74,000 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$130,927,000 (-7.22%) | -$122,116,000 (20.98%) | -$154,536,000 (-6.18%) | -$145,540,000 (-23.86%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$130,927,000 (-7.22%) | -$122,116,000 (20.98%) | -$154,536,000 (-6.18%) | -$145,540,000 (-23.86%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$130,927,000 (-7.22%) | -$122,116,000 (20.98%) | -$154,536,000 (-6.18%) | -$145,540,000 (-23.86%) |
Weighted Average Shares | $19,782,000 (96.21%) | $10,082,000 (1.58%) | $9,925,100 (1.24%) | $9,803,900 (15.14%) |
Weighted Average Shares Diluted | $19,782,000 (96.21%) | $10,082,000 (1.58%) | $9,925,100 (1.24%) | $9,803,900 (15.14%) |
Earning Before Interest & Taxes (EBIT) | -$130,927,000 (-6.28%) | -$123,194,000 (20.24%) | -$154,462,000 (-6.13%) | -$145,540,000 (-25.04%) |
Gross Profit | $1,000,000 (-72.22%) | $3,600,000 (0%) | $0 (0%) | $7,500,000 (0%) |
Operating Income | -$139,159,000 (-7.92%) | -$128,942,000 (17.94%) | -$157,135,000 (-7.54%) | -$146,122,000 (-23.88%) |
ADVM Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$41,889,000 (-143.24%) | $96,875,000 (-31.64%) | $141,720,000 (80.06%) | $78,709,000 (128.09%) |
Net Cash Flow from Financing | $120,003,000 (173817.39%) | $69,000 (-88.63%) | $607,000 (-74.68%) | $2,397,000 (-99.33%) |
Net Cash Flow from Operations | -$92,462,000 (-1.72%) | -$90,902,000 (15.90%) | -$108,091,000 (-0.24%) | -$107,831,000 (-35.99%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$14,348,000 (-337.47%) | $6,042,000 (-82.35%) | $34,236,000 (228.10%) | -$26,725,000 (-669.51%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$41,501,000 (-142.49%) | $97,683,000 (-36.38%) | $153,536,000 (63.63%) | $93,832,000 (134.97%) |
Capital Expenditure | -$388,000 (51.98%) | -$808,000 (93.16%) | -$11,816,000 (21.87%) | -$15,123,000 (-27.68%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | -$240,000 (-293.44%) |
Issuance (Purchase) of Equity Shares | $120,003,000 (24440.49%) | $489,000 (-19.44%) | $607,000 (-76.98%) | $2,637,000 (-99.26%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $14,350,000 (-18.32%) | $17,569,000 (-12.50%) | $20,079,000 (-20.30%) | $25,194,000 (23.55%) |
Depreciation Amortization & Accretion | $25,148,000 (5.61%) | $23,812,000 (125.32%) | $10,568,000 (127.51%) | $4,645,000 (11.71%) |
ADVM Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% | - | 100.00% |
Profit Margin | -13092.70% (-285.98%) | -3392.10% | - | -1940.50% |
EBITDA Margin | -10577.90% (-283.17%) | -2760.60% | - | -1878.60% |
Return on Average Equity (ROAE) | -92.70% (12.96%) | -106.50% (-58.01%) | -67.40% (-68.50%) | -40.00% (-26.58%) |
Return on Average Assets (ROAA) | -56.00% (0.36%) | -56.20% (-29.49%) | -43.40% (-42.76%) | -30.40% (-8.19%) |
Return on Sales (ROS) | -13092.70% (-282.59%) | -3422.10% | - | -1940.50% |
Return on Invested Capital (ROIC) | -77.10% (1.15%) | -78.00% (-70.68%) | -45.70% (-58.68%) | -28.80% (12.99%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -0.7 (-13.34%) | -0.62 (-67.65%) | -0.37 (68.80%) | -1.19 (84.86%) |
Price to Sales Ratio (P/S) | 92.38 (338.18%) | 21.08 | - | 23.01 |
Price to Book Ratio (P/B) | 1.37 (21.49%) | 1.13 (255.66%) | 0.32 (-41.76%) | 0.55 (-77.56%) |
Debt to Equity Ratio (D/E) | 1.54 (17.16%) | 1.32 (88.41%) | 0.7 (78.77%) | 0.39 (252.25%) |
Earnings Per Share (EPS) | -6.62 (45.33%) | -12.11 (22.37%) | -15.6 (-5.41%) | -14.8 (-7.25%) |
Sales Per Share (SPS) | 0.05 (-85.71%) | 0.36 (0%) | 0 (0%) | 0.77 (0%) |
Free Cash Flow Per Share (FCFPS) | -4.69 (48.39%) | -9.1 (24.71%) | -12.08 (3.67%) | -12.54 (-17.17%) |
Book Value Per Share (BVPS) | 3.58 (-46.39%) | 6.67 (-63.54%) | 18.29 (-43.29%) | 32.25 (-36.78%) |
Tangible Assets Book Value Per Share (TABVPS) | 9.09 (-41.16%) | 15.45 (-50.27%) | 31.07 (-30.73%) | 44.85 (-20.86%) |
Enterprise Value Over EBIT (EV/EBIT) | 0 (0%) | 0 (0%) | 0 (0%) | -2 (77.78%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -0.61 (-83.83%) | -0.33 (26.43%) | -0.45 (74.68%) | -1.79 (80.07%) |
Asset Turnover | 0 (-76.47%) | 0.02 (0%) | 0 (0%) | 0.02 (0%) |
Current Ratio | 5.73 (11.47%) | 5.14 (-12.98%) | 5.91 (-60.26%) | 14.88 (-28.54%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$92,850,000 (-1.24%) | -$91,710,000 (23.52%) | -$119,907,000 (2.48%) | -$122,954,000 (-34.91%) |
Enterprise Value (EV) | $64,922,502 (95.33%) | $33,237,257 (-49.12%) | $65,323,970 (-74.14%) | $252,633,678 (-74.98%) |
Earnings Before Tax (EBT) | -$130,927,000 (-6.28%) | -$123,194,000 (20.24%) | -$154,462,000 (-6.13%) | -$145,540,000 (-25.04%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$105,779,000 (-6.44%) | -$99,382,000 (30.93%) | -$143,894,000 (-2.13%) | -$140,895,000 (-25.54%) |
Invested Capital | $180,352,000 (41.59%) | $127,376,000 (-57.36%) | $298,753,000 (-38.12%) | $482,817,000 (13.74%) |
Working Capital | $108,402,000 (30.93%) | $82,792,000 (-47.72%) | $158,349,000 (-46.47%) | $295,825,000 (-28.47%) |
Tangible Asset Value | $179,841,000 (15.45%) | $155,768,000 (-49.49%) | $308,372,000 (-29.87%) | $439,727,000 (-8.88%) |
Market Capitalization | $97,147,502 (27.74%) | $76,053,257 (31.60%) | $57,792,970 (-66.54%) | $172,747,678 (-83.65%) |
Average Equity | $141,286,750 (23.17%) | $114,712,000 (-49.96%) | $229,232,250 (-37.03%) | $364,036,750 (-1.98%) |
Average Assets | $233,961,750 (7.63%) | $217,386,000 (-38.90%) | $355,770,750 (-25.80%) | $479,501,500 (14.85%) |
Invested Capital Average | $169,722,250 (7.47%) | $157,925,500 (-53.25%) | $337,840,000 (-33.22%) | $505,868,750 (43.88%) |
Shares | 20,802,463 (105.91%) | 10,102,717 (1.30%) | 9,972,902 (1.61%) | 9,815,209 (0.69%) |
